ELTP News and Press, Elite Pharmaceuticals Inc. From 08/09/19

Elite Pharmaceuticals ( OTCQB:ELTP ): Q1 GAAP EPS of $0.00. Revenue of $3.36M (+54.8% Y/Y) Press Release More news on: Elite Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,

Conference Call Scheduled for Monday, August 12th at 10:00 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 9, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP) , a specialty pharmaceutical company developing abuse-deterrent opioids and niche gener...

Financials for First Quarter Fiscal Year 2020 Ended June 30, 2019 will be released August 9, 2019 NORTHVALE, NJ / ACCESSWIRE / August 7, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company de...

NORTHVALE, NJ / ACCESSWIRE / June 28, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB: ELTP) announced today that marketing partner Lannett Company, Inc. ("Lannett"), has commenced product launch of Elite's generic Dantrolene Capsules. Elite entered into a license, supp...

Elite Pharmaceuticals, Inc. (ELTP) Q4 2019 Results Earnings Conference Call June 24, 2019, 11:30 AM ET Company Participants Nasrat Hakim - Chairman, President and CEO Carter Ward - CFO Conference Call Participants Presentation Operator Good morning, ladies and gentlem...

Elite Pharmaceuticals ( OTCQB:ELTP ): FY GAAP EPS of -$0.01. More news on: Elite Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Conference Call Scheduled for Monday, June 24h at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 21, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, announced r...

Elite Pharmaceuticals, Inc. Delays Fourth Quarter and Year End 2019 Earnings Release Date and Conference Call NORTHVALE, NJ / ACCESSWIRE / June 14, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB: ELTP), announced today that it has delayed its previously announced e...

Financials for Fiscal Year Ended March 31, 2019 will be released June 14, 2019 NORTHVALE, NJ / ACCESSWIRE / June 11, 2019 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche...

NORTHVALE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) announced today that it has entered into a license, supply, and distribution agreement (“Agreement”) with Lannett Company, Inc. (“Lannett ...